Your trusted source for investing success

Tag: sales

Capstone Mining First Quarter 2017 Financial Results

Capstone Mining Corp. (“Capstone” or the “Company”) (TSX: CS) today announced its financial results for the quarter ended March 31, 2017. Cash flow from operating activities was $22.0 million or $0.06 per share. The net loss for the period was $7.4 million or $0.02 per share and the adjusted net

Teck Reports Unaudited First Quarter Results for 2017

Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) reported profit attributable to shareholders of $572 million ($0.99 per share) compared with $94 million ($0.16 per share) a year ago. Adjusted profit attributable to shareholders was $671 million, or $1.16 per share, compared with $18 million, or $0.03 per

BioSig Technologies Provides Shareholder Update

BioSig Technologies Provides Shareholder Update

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today provided a shareholder update and highlighted the company’s recent achievements it has reached during the first part of

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network